Alfredo Damasceno

• Abstract

  Multiple Sclerosis (MS) is one of the main neurological diseases affecting the young adult population, significantly impacting their daily activities. It is a disabling and autoimmune disease, with no clear etiology, different symptoms and a complex and time-consuming diagnosis. Has a unpredictable course, with different possible patterns, which makes it difficult to choose efficient ther…

  Analysis of parameters and prognostic factors associated with a benign evolution in Multiple Sclerosis patients, BP.IC

• Abstract

  Multiple Sclerosis (MS) is a demyelinating and inflammatory disease of the central nervous system which causes a high socioeconomic cost for health care systems and society as a whole. Over the last decade, the scenario of available disease-modifying therapies (DMT) for MS has rapidly changed and has incorporated drugs that surpass in efficacy the first approved DMTs. Nevertheless, therap…

  A longitudinal evaluation of the relationship between no evidence of disease activity and progression of cerebral atrophy and cognitive dysfunction in patients with multiple sclerosis, BP.PD
• Longitudinal evaluation of cerebral atrophy and cortical thickness and its relationship with clinical and immunological factors in patients with multiple sclerosis, BP.DD

(Only some records are available in English at this moment)